A list of all stock ideas published by Simons Chase that could be considered by the SEC as recommendations
NVO - Video:“The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists” - February 2024
NRBO - “Dual Agonists Push Weight Loss Drug Companies Into Full Bandwagon Mode” - January 2024
XOM - Video:“Zoom Chat: How To Approach Opportunities In Guyana’s Oil Boom” - December 2023
INTS - “Interview with Lew Bender, President, Intensity Therapeutics” - December 2023
MAMA - “Mama’s Creations Inc” - September 2023
RIO - “Bard: Tell Me How Important Copper Is To Rio Tinto's Future Revenues” - June 2023
ENVX - “Battery Innovation and Enovix Corp” - April 2023
NYCB, RITM - “Two Ideas Emerge In The Banking Crisis” - April 2023
PROK - “ProKidney” - October 2022
CVX, TDW, PLL, PFIE, MPLX, DB, OIH - “Investing In Greta’s Game Of Russian Roulette” - August 2022
PFIE - “Profire” - June 2022
PLL “Piedmont Lithium” - May 2022
PLL & LLKKF “How Technology Is Driving Lithium Demand And Supply” - December 2021
SQZ - “Screening Synthetic Biology Companies” - February 2021
SQZ - “A Serendipitous Discovery Is At The Heart Of SQZ Biotech” - November 2020
“IPO: Grail, Inc Aims To Bring Liquid Biopsy To Healthcare” - September 2020
“Synthetic.com Interview With Jo Bhadki, CEO, Quantgene” - September 2020
“Back in the USSR” - June 2020
Podcast Interview with James Kunstler - June 2020
NYMTM - “Here’s An Example Of Extraordinary Value In the Wreckage of Panic Selling” - March 2020
“Evaluating Enterprise Cloud Stocks Through A Thematic Growth Lens” - September 2019
MPLX - “This High Quality Mid-Stream Energy Company Hits Multi-Year Low” - August 2019
TDOC - “These Two Junk Food Companies Point To A Major Healthcare Opportunity” - July 2019
BPRMF - “The Emerging Robotics Process Automation (RPA) Industry” - April 2019, & “Here Is The Only Public Company With Direct Exposure To RPA” - July 2019
TRHC - “Why U.S. Political Risk Should be A Factor in Portfolio Risk Budgets” - April 2019
TSLA - “Musk Brings Enormity Back To The Speculative Genre” - November 2018
CGC - “Here Is A Publicly Traded Cannabis Company You Can Get Behind” - September 2017
XON - “Intrexon: A Case Study In How To Invest Like A VC” - January 2014
SODA - “Two Perspectives On Food Innovation: Sodastream Vs. Monster Beverage” - September 2013
SU - “Suncor Energy By The Numbers (2002)” - January 2012
Published on Synthetic.com
CRISPR-Based Therapies Revolutionize the Treatment of Sickle Cell Disease, Underwhelm Investors - December 2023
IPO: Sensei Bio, Training The Immune System to Fight Cancer - February 2021
Decipher Biosciences - January 2021
Cullinan Oncology - January 2021
AbCellera Biologics - December 2020
Codiak Biosciences - October 2020
SQZ Biotechnologies Company - October 2020
Beam Therapeutics - October 2020
Harmony Biosciences - August 2020
Inhibrxs - August 2020
Panacea Acquisition Corp - August 2020
Freeline Therapeutics - July 2020
CureVac - July 2020
iTeos Therapeutics - July 2020
Berkeley Lights - July 2020
Relay Therapeutics - July 2020
Repare Therapeutics - July 2020
Yield10 Biosciences - July 2020
TWST - “Twist Bioscience Corporation IPO” - June 2020
“IPO: Yield10 Bioscience, Inc” - June 2020
“IPO: Amyris Inc” - June 2020
It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities on this list.
The content presented in this website does not constitute a recommendation to buy or sell any security. The content is produced without regard to individual levels of sophistication or investment experience, and without regard to the suitability of individuals who may access the content.
Investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.
You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. Neither SC Capital Management LLC nor any of its contributors are responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made on this site do not provide, imply, or otherwise constitute a guarantee of performance. It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the securities in this list.
SC Capital Management LLC posts may contain financial reports and economic analysis that embody a unique view of trends and opportunities. Accuracy and completeness cannot be guaranteed. Investors should be aware of the risks involved in stock investments and the possibility of financial loss. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied.
The material on this website are provided for information purpose only. SC Capital Management LLC does not accept liability for your use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties or conditions of any kind.